NOVOCURE LTD (NVCR)

JE00BYSS4X48 - Common Stock

28.91  -0.1 (-0.34%)

After market: 28.92 +0.01 (+0.03%)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2024-9-30)
2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
577.74M509.34M537.80M535.00M494.40M
Cost Of Goods
136.22M128.28M114.90M114.90M106.50M
Gross Profit
441.52M381.06M423.00M420.20M387.90M
Operating Expenses
598.42M613.93M512.50M464.50M357.50M
Research and Development
212.47M223.06M206.10M201.30M132.00M
Selling, General, and Administrative Expenses
385.96M390.87M306.40M263.20M225.50M
Operating Income
-156.91M-232.87M-89.50M-44.30M30.40M
Interest Income/Expense
44.42M15.46M3.50M-7.30M-13.20M
Other Income/Expense
N/A25.66M4.10M-500.00K900.00K
Non Recurring Items
N/AN/AN/AN/AN/A
Income Before Taxes
-114.49M-191.74M-81.80M-52.10M18.10M
Income Tax
35.29M15.30M10.70M6.30M9.60M
Net Income
-149.78M-207.04M-92.50M-58.40M19.80M
EBITDA
-146.06M-221.90M-78.88M-34.05M39.55M
 
Per Share Data
EPS Diluted Total Ops
-1.39-1.95-0.88-0.560.18
Non GAAP EPS
-1.40-1.95-0.88-0.560.19
 
Statistics
Gross Profit Margin
76.42%74.81%78.65%78.54%78.46%
Profit Margin
-25.93%-40.65%-17.20%-10.92%4.00%
Operating Profit Margin
-27.16%-45.72%-16.64%-8.28%6.15%

All data in USD

Charts